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Abstract
The gene for a eukaryotic phenolic acid decarboxylase of Candida guilliermondii was cloned, sequenced, and
expressed in Escherichia coli for the first time. The structural gene contained an open reading frame of 504 bp,
corresponding to 168 amino acids with a calculated molecular mass of 19,828 Da. The deduced amino sequence
exhibited low similarity to those of functional phenolic acid decarboxylases previously reported from bacteria with
25-39% identity and to those of PAD1 and FDC1 proteins from Saccharomyces cerevisiae with less than 14%
identity. The C. guilliermondii phenolic acid decarboxylase converted the main substrates ferulic acid and p-
coumaric acid to the respective corresponding products. Surprisingly, the ultrafiltrate (Mr 10,000-cut-off) of the cell-
free extract of C. guilliermondii remarkably activated the ferulic acid decarboxylation by the purified enzyme,
whereas it was almost without effect on the p-coumaric acid decarboxylation. Gel-filtration chromatography of the
ultrafiltrate suggested that an endogenous amino thiol-like compound with a molecular weight greater than Mr
1,400 was responsible for the activation.
Keywords: phenolic acid decarboxylase, ferulic acid decarboxylase, p-coumaric acid decarboxylase, Candida guillier-
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Introduction
Ferulic acid (FA), a derivative of 4-hydroxycinnamic
acid, is found in cell walls primarily as an ester linked to
lignin and other polysaccharides in cell walls, leaves and
seeds of plants such as in rice, wheat, and oat [Mathew
and Abraham 2004]. Bacterial phenolic acid decarboxy-
lases (PADs), which decarboxylate FA, p-coumaric acid
(PCA), and/or caffeic acid (CA) with concomitant pro-
duction of 4-vinylguaiacol (4VG), 4-vinylphenol (4VP),
and/or 4-vinylcatechol, respectively (see Additional file
1), are responsible for the detoxification of these 4-
hydroxycinnamic acids [Huang et al. 1994,Degrassi et al.
1995,Cavin et al. 1997b,1998]. [Zago et al. (1995)] first
succeeded in sequencing and expression of a bacterial
PAD (FA decarboxylase from Bacillus pumilus) in
Escherichia coli. The genetic mechanism of bacterial
PAD expression has been well established by the
discovery of PadR-mediated response to 4-hydroxycin-
namic acids in Pediococcus pentosaceus [Barthelmebs et
al. 2000], Bacillus subtilis [Tran et al. 2008], and Lacto-
bacillus plantarum [Gury et al. 2009]. The 4VG formed
is valuable precursor in the biotransformation of flavors
and fragrances used in the food, pharmaceutical, and
cosmetic industries [Mathew and Abraham 2006,Priefert
et al. 2001]. Furthermore, this compound is sometimes
present as an aroma in beers and wines [Thurston and
Tubb 1981,Smit et al. 2003,Coghe et al. 2004,Oelofse et
al. 2008,Sáez et al. 2010]
Naturally-occurring phenolic acids are known to inhi-
bit the growth of yeasts such as Saccharomyces cerevi-
siae, Pichia anomala, Debaryomyces hansenii, and
Candida guilliermondii (Meyerozyma guilliermondii
comb. nov.; [Kurtzman and Suzuki 2010]) [Baranowski
et al. 1980,Stead 1995,Pereira et al. 2011]. S. cerevisiae
[Goodey and Tubb 1982,Clausen et al. 1994,Smit et al.
2003,Coghe et al. 2004], Brettanomyces bruxellensis
[Godoy et al. 2008], and C. guilliermondii [Huang et al.
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2011] are suggested to produce a PAD in response or
relation to 4-hydroxycinnamic acids.
Recently, we purified and characterized a highly active
substrate-inducible PAD from C. guilliermondii ATCC
9058 (CgPAD) [Huang et al. 2011]. CgPAD is heat-
labile, and its molecular mass determined by SDS-polya-
crylamide gel electrophoresis is about 20 kDa, which is
similar to those of yeast strains of Brettanomyces anom-
alus [Edlin et al. 1998] and B. bruxellensis [Godoy et al.
2008]. CgPAD was active toward 4-hydroxycinnamic
acid derivatives, PCA, FA, and CA, whose relative activ-
ity ratios are different from the PADs of B. anomalus
and B. bruxellensis.
In the case of C. guilliermondii ATCC 9058, CgPAD
may be induced by both PCA and FA, because the ratios
of decarboxylation activity toward FA to PCA in the
cell-free extracts were comparable to that of the purified
enzyme. However, 6-hydroxy-2-naphthoic acid (6H2N)
induced CgPAD 20- and 6-fold greater than FA and
PCA, respectively, and the ratios of decarboxylation
activity toward FA to PCA in the cells grown on differ-
ent carbon sources in the presence of the pseudo-indu-
cer were found to be increased remarkably [Huang et al.
2011]. There was a possibility that 6H2N induced
another FA decarboxylase distinct from CgPAD under a
defined condition, but such activity was not detectable
during the course of purification. In the present study,
to resolve this inconsistency, we sequenced the gene for
CgPAD and created recombinant enzymes. Unexpect-
edly, we found that the presence of dithiothreitol
(DTT), 2-mercaptoethanol, cysteine, and homocysteine
considerably accelerated the rates of FA decarboxylation
activity of the purified native and recombinant CgPAD,
while they did not affect those of their PCA decarboxy-
lation activity. We also demonstrated that an unidenti-
fied amino thiol-like compound in the ultrafiltrate of




FA, CA, 4VG, and 6H2N were purchased from Wako
Pure Chemical (Osaka, Japan). PCA was from MP Bio-
medicals (Solon, OH), and 4VP was from Sigma-Aldrich
(Steinheim, Germany). All other chemicals used were of
analytical grade.
Microorganisms and propagation
The source of PAD and its gene was C. guilliermondii
(M. guilliermondii) ATCC 9058. The enzyme was
induced aerobically by 6H2N (1 mM) in Yeast Nitrogen
Base (YNB; Invitrogen, Carlsbad, CA) broth containing
0.5% glucose as described [Huang et al. 2011]. Briefly,
the yeast was grown at 25°C for 1 d, with shaking, in
200-ml portions of the medium placed in 2-l flasks. E.
coli DH5a (Takara Bio, Otsu, Japan) and E. coli BL21
(DE3) (Takara Bio) were used for plasmid preparation
and sequencing and for expression and purification of
recombinant CgPAD, respectively. The transformed E.
coli cells were grown, with shaking, at 37°C in 50-ml
portions of Luria-Bertani broth plus ampicillin (100 μg
ml-1) placed in 500-ml flasks to an A600 of 0.5. After
adding isopropyl b-D-galactosyl pyranoside (0.1 mM) to
the culture, incubations were further continued at 18°C
for 24 h. After cells were collected by centrifugation
(12,000 × g for 10 min) at 4°C, cell pastes obtained from
600-ml culture were used as the starting materials for
enzyme purification.
Purification of native and recombinant forms of CgPAD
Enzyme purification was done at a temperature not
exceeding 4°C. The native CgPAD in C. guilliermondii
was purified by successive column chromatographies on
CM Toyopearl 650 M (Tosoh, Tokyo, Japan), DEAE
Toyopearl 650 M (Tosoh), and Bio-Gel P-100 (Bio-Rad,
Hercules, CA) columns, as described previously [Huang
et al. 2011].
The wild-type and mutant recombinant enzymes
highly expressed in E. coli cells were each purified by
essentially the same procedure as that of the native
enzyme [Huang et al. 2011]. The recombinant E. coli
cells were washed twice with saline and then suspended
in two volumes of the extraction buffer [20 mM sodium
phosphate buffer (pH 7.0) plus 1 mM each of phenyl-
methanesulfonyl fluoride, MgCl2, EDTA, and DTT]. The
cells were disrupted six times for 50 s each with glass
beads (0.5 mm in diameter) at 2,500 rpm in a homoge-
nizer (Multi-Beads Shocker; Yasui Kikai, Osaka, Japan).
After cell debris was removed by centrifugation (12,000
× g, 15 min), the supernatant obtained was applied
directly to a column of DEAE Toyopearl 650 M (2.5 cm
× 25.5 cm) previously equilibrated with 20 mM 2-mor-
pholinoethanesulfic acid/NaOH (MES) buffer (pH 6.5).
The column was initially washed with 200 ml of 50 mM
NaCl in MES buffer (pH 6.5), and proteins were eluted
with a 300-ml linear gradient of 50 mM to 0.5 M NaCl
in the buffer. The active fractions were immediately
concentrated and exchanged with 50 mM phosphate
buffer (pH 7.0) by ultrafiltration (Amicon Ultra-15;
Millipore, Billerica, MA) to a small volume. The concen-
trate was then put on a column of Bio-Gel P-100 (1.0
cm × 43 cm) equilibrated with 50 mM sodium phos-
phate buffer (pH 7.0) and eluted with the equilibration
buffer. The active fractions were combined and concen-
trated by ultrafiltration, and the concentrate was stored
at -20°C until use. Highly purified wild-type and mutant
recombinant enzymes were obtained approximately 2-
to 5-folds with yields of 40-70% within 2 d by the simple
Huang et al. AMB Express 2012, 2:4
http://www.amb-express.com/content/2/1/4
Page 2 of 10
purification procedure as judged by SDS-acrylamide gel
electrophoresis (see Additional file 2).
Assay of CgPAD activity
The enzyme assay method was essentially the same as
described previously [Huang et al. 2011]. The initial
velocity of decarboxylation activity was measured at 25°
C with 4-hydroxycinnamic acid as substrate. The reac-
tion mixture contained the suitably-diluted enzyme solu-
tion and a 5 mM substrate (neutralized with 1.0 N
NaOH) in 0.1 M sodium phosphate buffer (pH 6.0) in a
final volume of 1.0 ml. After the reactions were termi-
nated by boiling for 10 min, the products formed were
quantified by high-performance liquid chromatography
(HPLC) using a packed column for reversed phase chro-
matography (Cosmosil 5C18-MS-II, 4.6 mm × 150 mm;
Nacalai Tesque, Tokyo, Japan) with acetonitrile/0.05%
phosphoric acid (7:3, v/v) as the mobile phase at a flow
rate of 0.6 ml min-1. One U of enzyme activity was
defined as the amount of enzyme that released 1 μmol
of 4VG or 4VP per min. Because the product, 4-vinylca-
techol, from CA was not commercially available, the CA
decarboxylation activity was expressed as formation of
4VG. Protein concentrations were measured using a
BCA protein assay kit (Thermo Fisher Scientific, Rock-
ville, MD) with bovine serum albumin as the standard.
Sequencing of internal amino acid residues of CgPAD
Initially, peptides of native CgPAD were obtained by
treatment with CNBr or Staphylococcus aureus V8 pro-
tease. The CNBr cleavage was done essentially by the
method of [Steers et al. (1965)]. One mg of CgPAD was
dissolved in 0.2 ml of 70% formic acid and cleaved with
an excess of CNBr at room temperature for 24 h. After
the remaining CNBr was removed by a rotary evapora-
tor, the reaction mixture was filtered on a column of
TSK gel G2000SWXL (Tosoh, 0.78 cm × 30 cm) in 30%
acetic acid. The digestion of CgPAD with V8 protease
was performed at 37°C for 6 h in 50 mM ammonium
bicarbonate buffer (pH 7.8) plus 4 M urea and 2 mM
EDTA. The peptide fragments obtained were fractio-
nated by reverse-phase high-performance liquid chroma-
tography on a C4 column (3.9 mm × 150 mm, Waters,
Milford, MA). The amino acid sequences of peptides
derived from CNBr or V8 protease digestion of native
CgPAD were determined by automated sequential
Edman degradation using a PPSQ-23A protein sequen-
cing system (Shimadzu, Kyoto, Japan).
Cloning and sequencing of CgPAD gene
All primers used are presented in Additional file 3. By a
reverse transcription polymerase chain reaction using
appropriate degenerate primers, the internal cDNA
fragments of CgPAD were sequenced. Total RNA was
isolated from C. guilliermondii using an RNeasy kit
(Qiagen, Valencia, CA). First-strand cDNA synthesis
was performed with 5 μg of total RNA using a GeneRa-
cer kit (Invitrogen, Carlsbad, CA) with oligo(dT) adaptor
primer. The cDNA obtained was used as a template for
PCR amplification with degenerate primers. The first
PCR was performed with primers P1 (a forward primer
designed from an internal LKNKHFQYTYDNGW-
KYEFHV) and P2 (a reverse primer designed from an
internal AFSQGHWEHPEQAHGDKRED), and nested
PCR was done with P1 and P3 (a reverse primer
designed from an internal AFSQGHWEHPE-
QAHGDKRED) (the sequences used for primer design
are underlined). The nested PCR product was then
cloned into a pGEM-T vector (Promega, Madison, WI)
and sequenced using the ABI Prism system (Model 310;
Applied Biosystems, Foster City, CA).
To obtain the entire gene for CgPAD, both 5’ and 3’
rapid amplification of cDNA ends (RACE) were per-
formed using a GeneRacer kit according to the manu-
facturer’s instructions. The gene-specific primers P4
(first PCR) and P5 (nested PCR) were used for the 5’-
RACE and the gene-specific primers P6 (first PCR) and
P7 (nested PCR) for the 3’-RACE. Approximately 250
bp and 290 bp were amplified by 5’-RACE and 3’-RACE,
respectively. Finally, a cDNA fragment containing the
entire coding region of CgPAD cDNA was amplified
using the forward primer P8 (designed from the 5’-
RACE product) and reverse primer P9 (designed from
the 3’-RACE product).
The nucleotide sequence of CgPAD was submitted to
DDBJ under the accession number AB663499
Site-directed mutagenesis
The entire CgPAD gene was amplified by PCR and
cloned into the NdeI/HindIII site of pET-22b (+) (Nova-
gen, Darmstadt, Germany), yielding the construct desig-
nated pPAD22b. Amino acid replacements were
performed using a QuikChange II site-directed muta-
genesis kit (Stratagene, La Jolla, CA). PCR was per-
formed using PfuUltra HF DNA polymerase (Promega)
with pPAD22b as the template. The primer sets used
were 5’-CATGGGGGGCCACTGGCTGGACGGCAC-3’/
5’-GTGCCGTCCAGCCAGTGGCCCCCCATG-3’ for
the Met57®Leu (M57L) mutation, 5’-CATGGGGGGC-
CAACGGCTGGACGGCAC-3’/5’-
GTGCCGTCCAGCCGTTGGCCCCCCATG-3’ for the
M57T mutation, and 5’-CATGGGGGGC-
CAGCGGCTGGACGGCAC-3’/5’-
GTGCCGTCCAGCCGCTGGCCCCCCATG-3’ for the
M57A mutation (the underlined sequences indicate
mutated codons). To express mutant proteins, the
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resulting plasmids harboring the respective mutated
genes were each introduced into competent E. coli BL21
(DE3) cells.
Construction of model structure of CgPAD
The secondary structure of CgPAD was predicted by the
method of [Kabsch and Sander (1983)]. The deduced
amino acid sequence of the enzyme was aligned with
that of the crystal structure of a PAD (PCA decarboxy-
lase) from L. plantarum (LpPAD; PDB code 2GC9)
[Rodríguez et al. 2010]. A model of the CgPAD struc-
ture built with method of homology modeling was con-
structed based on the structure of LpPAD [Sali et al.
1993]. All data sets were processed on a Windows XP
personal computer using the Discovery Studio software
package (Accelrys, San Diego, CA). Distance between
intramolecular sulfur atom of methionine and side-chain
carbonyl oxygen atoms of glutamic acid or amide nitro-
gen atom of arginine was calculated from the coordinate
values. The figure was prepared using a DS Visualizer
(Accelrys).
Results
Nucleotide and deduced amino acid sequences of CgPAD
We initially cloned and sequenced the CgPAD gene.
The entire CgPAD gene was 504 nucleotides in length,
and an open reading frame encoded 168 amino acid
residues (Figure 1). The calculated molecular mass was
19,828 Da http://web.expasy.org/compute_pi/, a value
very close to the 20 kDa determined for the native
enzyme by SDS-polyacrylamide gel electrophoresis
[Huang et al. 2011].
The deduced amino acid sequence of CgPAD was
aligned with those of functional PADs reported to date
from different bacteria [Thompson et al. 1997]; http://
www.genome.jp/tools/clustalw). As shown in Figure 2,
CgPAD exhibited very low similarity of sequence to
functional PADs reported to date from L. plantarum
WCFS1 ([Rodríguez et al. 2010] and L. plantarum
LPCHL2 [Cavin et al. 1997a] with 39%, Enterobacter sp.
Px6-4 [Gu et al. 2011a,2011b] with 34%, Klebsiella oxy-
toca [Uchiyama et al. 2008] with 27%, and B. subtilis
168 [Cavin et al. 1998] with 26% identity, and B. pumi-
lus PS213 [Zago et al.1995], P. pentosaceus ATCC
25745 [Barthelmebs et al. 2000], and Lactobacillus brevis
ATCC 367 (RM84) [Landete et al. 2010] each with 25%
identity. Nevertheless, four residues (Tyr18, Tyr20,
Arg48, and Glu71) involved in the catalysis of LpPAD
[Rodríguez et al. 2010] were well conserved in CgPAD
as Tyr30, Tyr32, Arg60 [but Asn23 in the Enterobacter
enzyme [Gu et al. 2011b]], and Glu82 and of PADs
from other bacteria as these residues at the correspond-
ing positions.
Construction of model structure and creation of mutant
proteins of CgPAD
The absence and/or replacement of methionine residues
adjacent to catalytic residues or in the proximate area of
active-site pockets has been reported to confer resis-
tance to oxidation, as based on the catalytic activity of
enzymes [Estell et al. 1985,Hagihara et al. 2001,2003,
Nonaka et al. 2003]. Further, we demonstrated that the
replacement or oxidation of such the Met residues
altered the conversion rates of substrates by some
enzymes [Hagihara et al. 2001,2003,Nonaka et al.
2003,2004,Saeki et al. 2007]. Then, we first postulated
that the fluctuation of the ratio of decarboxylation
toward FA to PCA might result from oxidation of heat-
labile CgPAD, because the deduced amino acid
sequence contained two oxidizable Met residues at posi-
tions 57 and 103 (Figure 1). It was expected that the
replacement of either Met57 or Met 103 with the non-
oxidizable amino acids would increase the ratio of dec-
arboxylation activity of CgPAD toward FA to PCA.
According to this scenario, we constructed a model of
CgPAD using the crystal structure of LpPAD (PDB code
2GC9) as the template. In the result, the Met residues
at positions 57 and 103 in the modeled CgPAD
appeared to be located in the active-site pocket (see
Additional file 4). Especially, the Met57 residue is
located at the entrance of the pocket and in the
immediate vicinity of possible catalytic residues Arg60
and Glu82. However, the Met103 residue is spatially
more distant from the two catalytic residues and located
deeper in the active-site pocket (see Additional file 5).
Therefore, we selected the Met57 residue as the target
for site-directed mutagenesis and created the mutant
enzymes with M57L, M57T, and M57A. The recombi-
nant wild-type and mutant enzymes expressed in E. coli
cells, together with the native enzyme from C. guillier-
mondii, were each purified to homogeneity (see Addi-
tional file 2). Contrary to our expectation, a mutant
enzyme with M57L did not increase the ratio of decar-
boxylation activity of CgPAD toward FA to PCA com-
pared with the native and recombinant wild-type
enzymes, as shown in Table 1. The activities toward
both substrates of the mutants with M57T and M57A
were practically negligible.
Acceleration of FA decarboxylation activity of CgPAD by
thiol compounds
For measurement of enzyme activities in the cell-free
extracts, we disrupted the cells in the extraction buffer
supplemented with 1 mM DTT. Then, we examined the
effect of this thiol on the activity of purified native
CgPAD. As the result, the FA decarboxylation activity
was found to be enhanced by DTT at 0.2-1 mM (Figure
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3), while the PCA decarboxylation activity was not
affected by DTT at the concentrations examined.
To further understand the unexpected positive effect
of DTT, we examined the effects of various thiol-con-
taining amino acids and chemical reagents on both
activities. Positive effects on the FA decarboxylation
activity were also observed with 2-mercaptoethanol (5
mM) and sulfhydryl amino acids such as L-cysteine, D-
cysteine, and DL-homocysteine (1 mM each), and the
increases in the relative decarboxylation activities of FA
to PCA reached 2:1 to 3:1 when compared with the con-
trol (without thiol), as shown in Table 2. Cysteic acid (1
mM) was essentially without effect.
The possibility that the replacement of Met57 with
leucine disrupted the structural proper folding of
CgPAD was not excluded because its specific activity
was considerably lower than those of the native and
wild-type enzymes (Table 1). However, the positive
effect by L-cysteine (1 mM) on FA decarboxylation
activity was also observed with the M57L mutant
enzyme as well as with native and recombinant wild-
type forms, as shown in Table 3. Essentially, L-cysteine
was without effect on the decarboxylation activity
toward CA of the wild-type enzyme. The activity toward
CA of the M57L mutant enzyme was too low to evalu-
ate the effect of L-cysteine.
Activation of FA decarboxylation activity by ultrafiltrate
of cell-free extract
Finally, we supposed that C. guilliermondii inherently
possessed a physiological thiol activator, which might
have been removed during the enzyme purification.
Then, we prepared an ultrafiltrate of the cell-free extract
(Mr 10,000-cut-off) of induced C. guilliermondii cells
Figure 1 Nucleotide and deduced amino acid sequences of CgPAD. The primers used for cloning the CgPAD gene are indicated by arrows
above the nucleotide sequence. Dotted underlines indicate deduced amino acid sequences identical to those of the peptides derived from
CNBr and S. aureus V8 protease digestions of native CgPAD. The residues possibly involved in the catalysis, which are integrally conserved in
LpPAD [Rodríguez et al. 2010], are boxed.
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and incubated it with native and recombinant CgPADs
at 25°C for 20 min before enzyme assays. As the results
shown in Figure 4, the ultrafiltrate was found to remark-
ably increase the FA decarboxylation activities of both
enzymes (approximately up to 5-folds) with an increase
in its volume, while it exhibited little effect on their
PCA and CA decarboxylation activities. The ultrafiltrate
of the cell-free extract of recombinant E. coli did not
exhibit such an activation effect.
Partial purification of true activator in the ultrafiltrate
The ultrafiltrate was subjected to gel-filtration chroma-
tography on Bio-Gel P-2. As shown in Figure 5, a possi-
ble true activator associated with the FA
decarboxylation activity was detected in fractions corre-
sponding to a Mr larger than 1,400. The fractions
reacted positively with the 5,5’-dithio-bis(2-nitrobenzoic
acid) (DTNB) and ninhydrin reagents. In the presence
of 50 μl of the filtrate, the values of Km, kcat, and kcat/
Km for FA were 5.67 mM, 278 s
-1, and 49.0 s-1 mM-1,
whereas those of the control (without filtrate) were 5.31
mM, 89.7 s-1, and 16.9 s-1 mM-1, respectively.
Discussion
This study describes for the first time the cloning,
sequencing, and expressing the gene for a eukaryotic
PAD in E. coli. CgPAD exhibited very low sequence
similarity to reported functional PADs with 24-39%
identity. CgPAD showed 100% amino acid sequence
identity to a hypothetical protein (EDK35930; locus tag
PGUG_00028) in the genome of the yeast M. guillier-
mondii ATCC 6260 (AAFM00000000), and moderate
similarity (51-56% identity) to the internal sequences
of hypothetical proteins of unknown function in the
genomes of fungi including the genera Verticillium,
Neosartorya, Aspergillus, Schizophyllum, Ustilago, Spor-
isorium, Nectria, Gibberella, and Penicillium (data not
shown). Notably, CgPAD exhibited sequence similarity
to PAD1 (YDR538W) with less than 14% identity and
essentially no homology with FDC1 (YDR539W)
Figure 2 Multiple amino acid sequence alignment of CgPAD with functional PADs reported to date. The sequences used are L. brevis
ATCC 367 (RM84) (Lb; ABJ63379), P. pentosaceus ATCC 25745 (Pp; AJ276891), L. plantarum WCFS1 (Lp; PDB code 2GC9; gi93279967), L. plantarum
LPCHL2 (Ll; U63827), B. pumilus PS213 (Bap; X84815), B. subtilis 168 (Bs; AF017117), Enterobacter sp. Px6-4 (Px6-4; ACJ26748), and K. oxytoca (Ko;
BAF65031). The sequences were aligned using the ClustalW program. Residues identical to those in CgPAD are shaded. Possible catalytic residues
are indicated as open circles above the CgPAD sequence. Partially conserved Met residues are indicated as filled circle. Sequences of
homologous hypothetical proteins of unknown function in the reported genome sequences are not included in the multiple alignments.
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isolated from S. cerevisiae [Clausen et al. 1994,Mukai
et al. 2010].
There was a possibility that either Met57 or Met103
in CgPAD was located in the active-site pocket and oxi-
dized to methionine sulfoxide during growth or purifica-
tion. Accordingly, the massive sulfoxide group of the
oxidized Met residue in the CgPAD might hinder the
entry of FA (4-hydroxy-3-methoxycinnamic acid) due to
its 3-methoxy group, but not PCA (4-hydroxycinnamic
acid), to the active-site pocket. To understand the fluc-
tuation of the ratio of decarboxylation toward FA to
PCA of CgPAD, we constructed a model structure of
the enzyme and replaced the Met57 residue located at
the entrance of the pocket with non-oxidizable amino
acids by site-directed mutagenesis. However, a mutant
enzyme (M57L) did not increase the decarboxylation
ratio of FA to PCA, for instance. This may exclude the
possibility that oxidation of Met57, close to the catalytic
residues Arg60 and Glu82, alters the decarboxylation
Table 1 Substrate specificities of native and recombinant
enzymes




Native FA 378 ± 16 100
PCA 393 ± 6 104
CA 53 ± 9 14
Recombinant Wild-type
FA 260 ± 30 100
PCA 259 ± 4.0 100
CA 31.7 ± 2.8 12
M57L
FA 20.1 ± 0.3 100
PCA 20.5 ± 0.3 102
CA 2.93 ± 0.03 15
M57T
FA < 0.1 -
PCA < 0.1 -
CA < 0.01 -
M57A
FA < 1.0 -
PCA < 1.0 -
CA < 0.02 -
a The FA decarboxylation activities of the native and recombinant enzymes
are taken as 100% for each.
Figure 3 Effect of DTT on decarboxylation activities toward FA
and PCA of purified native CgPAD. DTT (0.2, 0.5, or 1 mM) was
added to the reaction mixtures containing ×10 enzyme (1.0-ml final
volume) and incubated at 25°C for 20 min. An aliquot (0.1 ml) was
withdrawn and added to 0.9 ml of the reaction mixture containing
0.1 M FA or PCA, and the initial velocities of decarboxylation of FA
(filled circle) and PCA (open circle) were measured under the
standard conditions of enzyme assay. The values obtained from
three separate experiments are shown and expressed as
percentages, taking the activity of each untreated enzyme as 100%.
The bars indicate the standard deviation at each point.
Table 2 Effects of thiol reagents on the activities of
native CgPAD
Additive (1 mM) Specific activity (U mg-1) FA/PCA
FA (%) PCA (%)
None 378 ± 16 (100) 393 ± 6 (100) 0.96
2-Mercaptoethanol (5 mM) 806 ± 56 (213) 440 ± 3 (112) 1.83
Dithiothreitol 1140 ± 177 (302) 598 ± 7 (112) 1.91
L-Cysteine 1130 ± 37 (299) 437 ± 39 (111) 2.59
D-Cysteine 1590 ± 252 (421) 590 ± 4 (150) 2.69
DL-Homocysteine 1830 ± 354 (484) 628 ± 9 (160) 2.91
Cysteic acid 557 ± 30 (147) 593 ± 9 (151) 0.94
Experimental conditions were the same as those described in Figure 3.
Table 3 Effect of L-cysteine on the activities of
recombinant wild-type and M57L mutant CgPAD
Substrate Specific activity (U mg-1) Relative activity b (%)
Wild type
FA 260 ± 9.0 100
FA + L-cysteine a 759 ± 156 292
PCA 259 ± 4.0 100
PCA + L-cysteine 257 ± 3.3 99
CA 31.7 ± 2.8 12
CA + L-cysteine 35.9 ± 3.5 14
M57L
FA 20.1 ± 0.3 100
FA + L-cysteine a 66.7 ± 8.5 332
PCA 20.5 ± 0.3 100
PCA + L-cysteine 26.0 ± 2.7 127
CA < 2.6 < 13
CA + L-cysteine ND c
Experimental conditions were the same as those described in Figure 3. a
Treated with 1 mM. b The activity toward FA is taken as 100%. c Not
determined.
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ratio of FA to PCA. A single Cys residue at position 66
could be responsible for the alteration of CgPAD activ-
ity. However, in the model of CgPAD we built, the
Cys66 residue is located deeper in the active-site pocket
and faced on the other side and far distant (7.2 Å) from
the indole ring of Trp80 which might interact with
Glu82 (data not shown). Essentially, conversion of
cysteine to cysteic acid during purification steps is unli-
kely because cysteine is oxidized by strong chemical
oxidants.
In this study, the activities toward substrates of the
M57T and M57A mutants, together with M57L mutant,
were found to be much lower than those of the native
and recombinant wild-type forms of CgPAD. This result
suggests that Met57 is one of the substrate-binding resi-
dues in the catalysis of CgPAD. In support of our view,
one of substrate-binding residues, Leu45, in the Entero-
bacter PAD [Gu et al. 2011b] is conserved as Met at the
corresponding positions in the aligned bacterial
enzymes. The corresponding residue in CgPAD is
Met57 in the model structure of CgPAD (see Additional
file 4).
Unexpectedly, we found that the rate of FA decarbox-
ylation activity, but not PCA decarboxylation activity, of
CgPAD was accelerated by DTT, 2-mercaptoethanol,
cysteine (both L- and D-forms), and DL-homocysteine,
which are antioxidants and/or reducing reagents. How-
ever, these chemical reagents cannot reduce oxidized
Met residues (methionine sulfoxide and methionine sul-
fonate) in protein molecules. Furthermore, L-cysteine
and L-homocysteine are involved in the trans-sulfuriza-
tion of amino acid metabolism (e.g., [Brosnan and Bros-
nan 2006]), both of which intracellular concentrations
are very lowered by strict regulatory control. These
results exclude the possibility that these amino acids are
the physiological activator for CgPAD.
Finally, we found that an amino thiol-like endogenous
factor in the ultrafiltrate of the C. guilliermondii cell-
free extract drastically enhanced the FA decarboxylation
activity. The kinetic data indicate that the ultrafiltrate
increases the maximal activity toward FA without alter-
ing of the affinity to the substrate. These findings led us
to conclude that a true activator for FA decarboxylation
activity is inherently present in the C. guilliermondii
cells. This also shows that the true activator was
removed during the enzyme purification. Such a cataly-
tic nature has never been reported in the literature.
Identification of the structure of the endogenous activa-
tor would explain the novel catalytic feature of CgPAD
and contribute to the clarification of physiological role
Figure 4 Effect of ultrafiltrate on activities of native (A) and
recombinant wild-type CgPAD (B). Cell pastes of 6H2N-induced C.
guilliermondii and recombinant E. coli were disrupted with glass
beads in the extraction buffer. The fresh cell-free extracts obtained
(5.8-7.5 mg protein ml-1) were ultrafiltered by centrifugation in an
Amicon Ultra-15. Aliquots (10 μl to100 μl) of the ultrafiltrate were
added immediately to the reaction mixture containing enzyme
(0.95-ml final volume), incubated at 25°C for 20 min, and then the
initial velocities toward substrates were measured by adding 50 μl
of a 0.1 M substrate. The values were obtained from several
separate experiments and are expressed as percentages, taking the
activity toward FA (filled circle), PCA (open circle), and CA (filled
triangle) of the untreated enzyme as 100%.
Figure 5 Gel-filtration chromatography of ultrafiltrate. One ml
of the ultrafiltrate prepared from the cell-free extract of induced C.
guilliermondii cells was applied to a Bio-Gel P-2 column (1.0 cm ×
50 cm) previously washed with distilled water and eluted with
distilled water. The column was calibrated with cyanocobalamin (a,
Mr = 1,355), cellobiose (b, Mr = 342), and glucose (c, Mr = 180), as
indicated by vertical arrows. The elution pattern was monitored by
measuring at 240 nm (dotted line). The fractions containing the
activator of FAD activity (filled circle) were examined for color
reactions with DTNB solution at 412 nm (open circle) and ninhydrin
solution at 570 nm (open triangle). The activation was expressed as
ΔU mg-1 [(activity + eluate)-(control activity)] after 20-min incubation
at 25°C. For the color reactions, 0.1-ml aliquots were added to 0.9
ml of 5 mM DTNB in 50 mM phosphate buffer (pH 7.5) and
ninhydrin solution, respectively.
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of PADs in some yeast cells. It is interesting to examine
whether such activation of eukaryotic PADs is observed
by ultrafiltrates of prokaryotes and vice versa.
[Rodríguez et al. (2010)] clarified by site-directed
mutagenesis of Arg48 and Glu71 in LpPAD that the
entrance region, particularly the b1-b2 and b3-b4 loops,
adopted a distinct closed conformation that decreased
the opening of the active-site cavity. Possible subsite
residues Tyr30 and Tyr32 and catalytic residue Glu82
along with Met57 of CgPAD are located on the b1-b2
loop and b3-b4 loop, respectively (see Additional file 4
A). It is possible that the physiological activator in the
ultrafiltrate and/or the tested thiol compounds induce
conformational change of the loops so that the entry of
FA is much easier than those of PCA and CA. CgPAD
exhibits low sequence similarity to LpPAD of known
structure, and we are now crystalizing CgPAD to solve
its X-ray structure.
Additional material
Additional file 1: Reaction scheme for CgPAD with different
substrates. Supplementary scheme 1.
Additional file 2: SDS-polyacrylamide gel electrophoresis of purified
enzymes. Supplementary figure 1.
Additional file 3: Primers for CgPAD cDNA cloning. Supplementary
table 1.
Additional file 4: A. Structure-based amino acid sequence alignment of
CgPAD with LpPAD of known structure (PDB code 2GC9). B. A model
structure of CgPAD incorporating possible catalytic residues Glu82 and
Arg60 residues and subsite residues Tyr30 and Tyr32, along with Met57
and Cys66. Supplementary figure 2.
Additional file 5: A. A CPK model of CgPAD. B. Coordination of the
catalytic residues in the surrounding Met57 (upper) and Met103 (lower)
in the model CgPAD structure. Supplementary figure 3.
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